Ganciclovir Ophthalmic Gel 0.15% w/w: Uses, Dosage, Benefits, and Side Effects

CIPVISION GIVOSIRUN is an antiviral ophthalmic preparation developed through clinical trials that is made by Steris Healthcare (sterisonline) and whose key ingredient is ganciclovir 0.15% w/w. This preparation is specially intended for treating the surface of the eye, and it ensures better contact of the drug with cornea than conventional eye drops do.

The active component of ganciclovir ophthalmic gel 0.15% w/w is a representative of the nucleoside analogs group. This compound acts through selective inhibition of herpes viruses' reproduction in corneal cells, thus preventing spreading of the virus and restoring health of the organ itself. Gel form provides prolonged staying in eye tissues; this increases efficiency of therapy, requiring less application of the agent than antiviral eye drops used earlier.

This brochure was developed by doctors of Steris Healthcare in order to provide information on ganciclovir ophthalmic gel 0.15 w/w, its correct administration, dosage regimen, safety of using the drug, and other issues related to its utilization.

.

 

What is Ganciclovir Ophthalmic Gel Used For?

Ganciclovir ophthalmic gel 0.15% w/w is used to treat acute herpetic keratitis (also called dendritic ulcers or superficial epithelial keratitis) caused by Herpes Simplex Virus (HSV) affecting the cornea. It is an antiviral eye gel that stops viral replication in the infected cells of the eye surface, reducing inflammation and promoting corneal healing.

The primary approved indication for ganciclovir ophthalmic gel 0.15 uses includes:

• Herpetic Keratitis (HSV Keratitis): The most common viral infection of the cornea. CIPVISION GIVOSIRUN targets the HSV-1 and HSV-2 virus strains that infect corneal epithelial cells.
• Dendritic Corneal Ulcers: These are characteristic branch-like ulcers on the corneal surface caused by active herpes simplex virus replication.
• Superficial Epithelial Keratitis: Early-stage viral eye infections affecting the outermost layer of the cornea respond well to ganciclovir ophthalmic gel.
• Recurrent Herpetic Eye Infections: In patients with a documented history of HSV keratitis who experience recurrent episodes.

It is important to note that ganciclovir ophthalmic gel 0.15 w/w is NOT indicated for bacterial, fungal, or allergic conjunctivitis. A qualified ophthalmologist must confirm a viral etiology before initiating treatment.

 

Treatment for Viral Eye Infection – How Ganciclovir Works

Viral eye infections, particularly those caused by Herpes Simplex Virus, are among the leading causes of corneal blindness worldwide. Understanding how ganciclovir ophthalmic gel combats these infections helps patients appreciate the importance of completing the full course of treatment.

Mechanism of Action

Ganciclovir is a synthetic analogue of the naturally occurring nucleoside guanosine. Within HSV-infected cells:

1. Ganciclovir is first phosphorylated by a viral enzyme (thymidine kinase) specific to HSV-infected cells — meaning it is selectively activated only where the virus is present.
2. It is then further converted to ganciclovir triphosphate, the active form.
3. Ganciclovir triphosphate competes with the natural nucleoside to inhibit viral DNA polymerase — the enzyme the virus needs to replicate its genetic material.
4. This stops viral replication, preventing the infection from spreading to healthy corneal cells.

This selective mechanism means that ganciclovir ophthalmic gel 0.15% is highly targeted, with minimal impact on healthy, uninfected human cells — making it both safe and effective as a topical ophthalmic treatment.

 

What is Ganciclovir Ophthalmic Gel 0.15% Used For – Clinical Indications

Ganciclovir ophthalmic gel 0.15% (CIPVISION GIVOSIRUN) is specifically used for: (1) acute herpetic keratitis, (2) dendritic ulcers of the cornea, (3) HSV epithelial keratitis. It is a prescription-only antiviral eye gel indicated for adults and adolescents (12 years and above) under ophthalmologist supervision.

Beyond the primary indication, clinicians may also use ganciclovir ophthalmic gel 0.15 w/w version as part of a broader treatment plan for:

• Post-surgical prophylaxis in patients with a history of HSV keratitis undergoing corneal procedures (refractive surgery, keratoplasty), where viral reactivation is a known risk.
• Combined antiviral therapy alongside oral antivirals (such as acyclovir or valacyclovir) for severe or deep stromal keratitis — at the ophthalmologist's discretion.
• Cytomegalovirus (CMV) Retinitis: While the systemic form of ganciclovir is approved for CMV retinitis, the 0.15% ophthalmic gel version is specifically formulated and indicated for corneal HSV infections.

 

Ganciclovir Ophthalmic Gel 0.15% w/w – How to Use

Correct application of CIPVISION GIVOSIRUN ganciclovir ophthalmic gel 0.15 w/w is critical for maximising treatment outcomes and minimising side effects. Follow the instructions provided by your ophthalmologist and the guidance below.

 

Ganciclovir Ophthalmic Gel – How to Apply (Step-by-Step Guide)

How to Apply Ganciclovir Gel to Your Eyes

1. Wash your hands thoroughly with soap and water before handling the gel tube.
2. Tilt your head back gently and look upward.
3. Pull down the lower eyelid of the affected eye to create a small pocket (conjunctival sac).
4. Squeeze approximately 1 cm (a small ribbon) of gel into the conjunctival sac — do not touch the tube tip to your eye or skin.
5. Gently close your eye for 1–2 minutes to allow the gel to distribute evenly across the eye surface.
6. Wipe away any excess gel with a clean tissue.
7. If using other eye drops, wait at least 15 minutes before or after applying ganciclovir gel.
8. Replace the cap on the tube immediately after use.

 

How Often Should I Apply Ganciclovir Gel? – Dosage & Schedule

The dosage of ganciclovir ophthalmic gel 0.15 w/w follows a two-phase protocol based on corneal healing status:

Phase	Frequency	Duration	Condition
Active Treatment Phase	5 times daily (every 3 hours while awake)	Until corneal ulcer heals (typically 7–14 days)	Active HSV keratitis / dendritic ulcer present
Maintenance Phase	3 times daily	7 days after healing	Post-healing consolidation to prevent relapse

 

Ganciclovir Eye Drops Dosage – Key Points

Although CIPVISION GIVOSIRUN is a gel (not drops), the dosing principles are similar. Key points to remember:

• Never exceed the prescribed frequency — more is not better and increases risk of side effects.
• Treatment should not exceed 21 days in total unless directed by your ophthalmologist.
• Do not stop treatment early even if symptoms improve — incomplete treatment can lead to viral resistance.
• Only one eye should be treated at a time unless specifically instructed otherwise.

 

How Many Times a Day Should I Use Ganciclovir Eye Gel?

During active infection: 5 times a day (approximately every 3 waking hours). After corneal healing is confirmed by your ophthalmologist: 3 times a day for 7 more days. Always follow your doctor's specific instructions for your condition.

 

Can Ganciclovir Cure Eye Herpes?

Here’s another commonly raised query on the topic of the ganciclovir eye gel. The answer to it entails making a crucial clarification that goes like this:

The use of ganciclovir eye gel is able to deal with and cure an active infection of herpes simplex virus affecting the eyes. However, it cannot cure the patient in the sense of eradicating the virus entirely from their body. Herpes simplex virus will continue being latent in the nerve ganglia and can become active again at a certain point in time. Ganciclovir simply deals with the active case and stops the virus from damaging the cornea any more than it already did.

Patients suffering from recurrent HSV keratitis might be put under the continuous administration of an oral antiviral therapy by their ophthalmologist to prevent recurrences.

 

Do I Need a Prescription for Ganciclovir Eye Gel?

Yes. Ganciclovir Ophthalmic Gel 0.15% w/w (CIPVISION GIVOSIRUN) is a Schedule H medication in India that can only be taken after a prescription from an ophthalmologist or physician. You should never buy it or use it without a prescription as using it incorrectly might worsen your condition and cause side effects.

In case you suspect a viral infection of the eye, you should visit an ophthalmologist urgently since herpes keratitis can cause scarring of the cornea and impair vision.

 

Can I Use Ganciclovir Eye Gel During Pregnancy?

Ganciclovir ophthalmic gel 0.15% w/w should be used during pregnancy only if the potential benefit justifies the potential risk. Here is what the evidence says:

• Ganciclovir is classified as FDA Pregnancy Category C — animal studies have shown embryotoxicity and teratogenicity at high systemic doses.
• With ophthalmic (topical eye) use, systemic absorption is minimal, but it cannot be guaranteed to be zero.
• Pregnant women with herpetic keratitis should consult their ophthalmologist and obstetrician jointly before starting treatment.
• Breastfeeding mothers should exercise caution; it is not known whether ganciclovir is excreted in human breast milk after topical eye use.

Important: Never self-administer ganciclovir ophthalmic gel during pregnancy or breastfeeding without explicit guidance from your treating doctor. The risk-benefit ratio must be assessed individually.

 

What Are the Side Effects of Ganciclovir Eye Gel 0.15%?

CIPVISION GIVOSIRUN is generally well-tolerated when used as directed. However, like all medicines, it may cause side effects in some patients. Below is a comprehensive overview:

Ganciclovir Ophthalmic Gel 0.15% w/w Side Effects

Common Side Effects

• Transient blurred vision after instillation (resolves within minutes)
• Mild burning or stinging sensation in the eye
• Eye irritation or discomfort
• Superficial punctate keratitis (tiny surface changes on cornea)
• Increased lacrimation (watering of the eye)
• Sensitivity to light (photophobia)

Rare / Serious Side Effects

• Allergic blepharitis (eyelid inflammation)
• Corneal epithelial defects (if overused)
• Severe allergic reaction (rash, swelling, breathing difficulty) – seek emergency care
• Ocular hypertension (rare)
• Contact dermatitis around the eye

When to Stop & See a Doctor: Discontinue use and consult your ophthalmologist immediately if you experience worsening eye pain, significant vision changes, swelling of the eye or eyelid, or any signs of a severe allergic reaction.

The gel formulation of CIPVISION GIVOSIRUN has a significantly lower systemic absorption compared to oral ganciclovir, which means the systemic side effects (bone marrow suppression, kidney toxicity) seen with IV ganciclovir are not expected with topical ophthalmic use.

 

Contraindications, Precautions & Drug Interactions

Contraindications

• Known hypersensitivity to ganciclovir, valganciclovir, acyclovir, or any component of the formulation.
• Do not use if wearing soft contact lenses (the preservative benzalkonium chloride may damage lenses; wait at least 15 minutes before reinserting).

Key Precautions

• For external ophthalmic use only — do not swallow or inject.
• Avoid touching the tip of the tube to any surface, eye, or skin to prevent contamination.
• Discard the tube 4 weeks after first opening, even if gel remains.
• Do not drive or operate machinery immediately after application due to temporary blurring of vision.
• Inform your ophthalmologist of all current medications, including other eye preparations.

Drug Interactions (Topical)

Drug interactions with topically applied ganciclovir ophthalmic gel 0.15% are considered minimal due to very low systemic absorption. However:

• If using multiple eye preparations, maintain a 15-minute interval between each application.
• Inform your doctor if you are on systemic antivirals or immunosuppressants.

 

Storage Instructions & Ganciclovir Ophthalmic Gel 0.15% w/w Price

Storage

• Store below 25°C in a cool, dry place away from direct sunlight.
• Do not refrigerate or freeze.
• Keep out of reach of children.
• Discard 4 weeks after opening the tube.
• Check expiry date before use.

Ganciclovir Ophthalmic Gel 0.15 w/w Price

The ganciclovir ophthalmic gel 0.15 w/w price for CIPVISION GIVOSIRUN by Steris Healthcare is competitively positioned to ensure patient affordability without compromising on pharmaceutical quality. For the most accurate and current pricing, please visit sterisonline.com or consult your pharmacist. Pricing may vary by region, retailer, and pack size.

 

Why Choose CIPVISION GIVOSIRUN by Steris Healthcare?

Steris Healthcare (sterisonline) is a trusted name in ophthalmic pharmaceutical manufacturing in India, committed to stringent quality standards and evidence-based formulations. CIPVISION GIVOSIRUN reflects this commitment through:

• Superior Gel Formulation: The gel matrix ensures prolonged corneal contact time compared to conventional antiviral eye drops, enabling better drug bioavailability at the site of infection.
• Clinically Validated Active: Ganciclovir 0.15% w/w has been studied in multiple randomised clinical trials and is recommended in international ophthalmology guidelines for herpetic keratitis.
• GMP-Compliant Manufacturing: Produced in WHO-GMP certified facilities under the highest quality control standards.
• Patient-Friendly Tube Design: Precision tip for accurate dosing with minimal wastage.
• Affordable Access: Steris Healthcare is committed to making quality ophthalmic medications accessible to patients across India.

Brand name: Cipvision Givosirun (STERIS HEALTHCARE PVT LTD)
Composition Name: Ganciclovir Opthalmic Gel 
Strength: 0.15% W/W
Formulation: Steriline Aqueous Gel Base 
Pack size: For 5 gm
Marketed By: Steris Healthcare Pvt Ltd
Regulatory standard: WHO-GMP certified
Schedule: Valid Prescription Required (prescription only)

 

Frequently Asked Questions (FAQs) – Ganciclovir Ophthalmic Gel 0.15% w/w

Q1. What is ganciclovir ophthalmic gel used for?

Ganciclovir ophthalmic gel 0.15% w/w (CIPVISION GIVOSIRUN) is used to treat acute herpetic keratitis — a viral infection of the cornea caused by Herpes Simplex Virus (HSV). It targets dendritic ulcers and superficial epithelial keratitis, stopping viral replication and allowing the eye to heal.

Q2. How do you apply ganciclovir gel to your eyes?

Wash hands, tilt your head back, pull down the lower eyelid, squeeze approximately 1 cm of gel into the conjunctival sac (lower eye pocket), close the eye for 1–2 minutes, and wipe excess away. Do not let the tube tip touch the eye. Wait 15 minutes before using other eye preparations.

Q3. How many times a day should I use ganciclovir eye gel?

5 times daily (every 3 waking hours) during active infection until the corneal ulcer heals, then 3 times daily for 7 further days. Do not exceed 21 days of treatment total without ophthalmologist review.

Q4. Can ganciclovir cure eye herpes?

Ganciclovir ophthalmic gel effectively clears an active herpes eye infection and heals corneal ulcers. However, it does not eliminate the latent herpes virus residing in nerve tissue. The virus can reactivate at a later date, particularly during illness, stress, or immunosuppression.

Q5. Do I need a prescription for ganciclovir eye gel?

Yes. CIPVISION GIVOSIRUN (ganciclovir ophthalmic gel 0.15% w/w) is a Schedule H prescription-only medicine in India. It cannot be dispensed without a valid prescription from a licensed ophthalmologist or physician.

Q6. What are the side effects of ganciclovir eye gel 0.15%?

Common: temporary blurred vision, mild stinging or burning, eye irritation, watering, light sensitivity. Rare: allergic reactions, eyelid inflammation, corneal damage from overuse. Systemic side effects are extremely rare with topical ophthalmic use.

Q7. Can I use ganciclovir eye gel during pregnancy?

Ganciclovir ophthalmic gel should only be used in pregnancy when the benefit clearly outweighs the risk, as assessed by an ophthalmologist and obstetrician together. Systemic absorption from eye gel is low but cannot be excluded. Avoid use during breastfeeding unless deemed essential by your doctor.

Q8. How long does it take for ganciclovir gel to work?

Most patients see noticeable improvement within 3–7 days of starting treatment. Complete corneal healing (re-epithelialisation) typically occurs within 7–14 days. The maintenance phase continues for 7 more days after healing to prevent relapse.

Q9. Can I wear contact lenses while using ganciclovir gel?

No. Contact lens wear is generally not recommended during an active eye infection. Furthermore, the preservative in ganciclovir ophthalmic gel (benzalkonium chloride) may discolour soft contact lenses. If you must use lenses, wait at least 15 minutes after applying the gel.

Q10. What is the price of ganciclovir ophthalmic gel 0.15% w/w (CIPVISION GIVOSIRUN)?

The ganciclovir ophthalmic gel 0.15 w/w price for CIPVISION GIVOSIRUN varies by pharmacy and region. Visit sterisonline.com or contact your nearest pharmacy for the latest MRP and availability. Steris Healthcare strives to keep this essential ophthalmic medicine affordable.

Q11. Is ganciclovir gel the same as acyclovir eye ointment?

Both treat HSV keratitis, but they are different drugs. Ganciclovir 0.15% ophthalmic gel has demonstrated comparable or superior efficacy to acyclovir 3% eye ointment in clinical studies, with the advantage of a gel vehicle that offers better corneal retention and comfort. They are not interchangeable without medical advice.

Q12. Can ganciclovir ophthalmic gel be used in children?

CIPVISION GIVOSIRUN is generally indicated for adults and adolescents aged 12 years and above. Use in younger children should only be considered under specialist paediatric ophthalmology supervision if clinically necessary.

 

Medical Disclaimer

This article is intended for informational purposes only and does not constitute medical advice. The information about CIPVISION GIVOSIRUN (ganciclovir ophthalmic gel 0.15% w/w) has been prepared by the Steris Healthcare medical team based on clinical data, prescribing information, and published guidelines. Always consult a qualified ophthalmologist or healthcare professional before starting, stopping, or changing any medication. Steris Healthcare (sterisonline) is not responsible for any clinical decisions made based solely on this content.